Marginal improvement in survival among patients diagnosed with metastatic prostate cancer in the second-line antiandrogen therapy era. uri icon

authors

  • Kim, Isaac E
  • Dall'Era, Marc A
  • Yi Kim, Isaac
  • Jang, Thomas L
  • Kim, Sinae
  • David Richard Lee, MD, MBA
  • Kim, Daniel D
  • Singer, Eric A
  • Ghodoussipour, Saum
  • Stein, Mark N
  • Aron, Monish

publication date

  • January 1, 2021